CDEK
← All drugs Report issue

balstilimab

mAbexperimental

Clinical trial activity

36 trials · 39 clinical orgs · 0 marketing orgs

Phase 1
11
Phase 2
26
Phase 3
4
Phase 4
0

Earliest trial started Jul 31, 2021 (NCT04943848)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07128355Early Phase 1 (Phase 1)Jan 31, 2026Agenus Inc., Harvard University
NCT07152821Phase 3Nov 30, 2025Agenus Inc., Australasian Gastro-Intestinal Trials Group, British Columbia Cancer Agency, Canadian Cancer Trials Group, UNICANCER
NCT07227636Phase 2Nov 7, 2025Agenus Inc., Memorial Sloan-Kettering Cancer Center
NCT07193862Early Phase 1 (Phase 1)Oct 15, 2025Northwell Health
NCT06780787Phase 2Jun 30, 2025City of Hope National Medical Center, National Cancer Institute (NCI)
NCT06843551Phase 2Jun 1, 2025Agenus Inc., University of Miami
NCT06782932Phase 1/Phase 2 (Phase 2)May 27, 2025Agenus Inc., Johns Hopkins University, Lustgarten Foundation, Oncovir, Inc.
NCT06843434Phase 2Feb 20, 2025Agenus Inc., Memorial Sloan-Kettering Cancer Center
NCT06411691Phase 1Nov 4, 2024Agenus Inc., Department of Defense, Johns Hopkins University, National Cancer Institute (NCI), National Institutes of Health (NIH)
NCT06575725Phase 2Nov 1, 2024City of Hope National Medical Center, National Cancer Institute (NCI)
NCT06346197Phase 3Oct 15, 2024Agenus Inc., Centre Leon Berard
NCT06268015Phase 2Oct 1, 2024Agenus Inc., Duke University, Gateway for Cancer Research
NCT06336902Phase 1Oct 1, 2024National Cancer Institute (NCI), University of Southern California
NCT06322108Phase 2May 31, 2024Agenus Inc.
NCT06300463Phase 2Mar 26, 2024Agenus Inc., Cornell University
NCT05864534Phase 2Mar 1, 2024Agenus Inc., CarThera, Northwestern University
NCT06251973Phase 2Feb 1, 2024Memorial Sloan-Kettering Cancer Center
NCT06279130Phase 2/Phase 3 (Phase 3)Jan 29, 2024Agenus Inc., Netherlands Cancer Institute
NCT06076837Phase 1Dec 31, 2023Agenus Inc., HonorHealth Research Institute, TGen Drug Development, University of Arizona
NCT05930951Phase 1Nov 29, 2023Groupe Oncologie Radiotherapie Tete et Cou
Showing 20 of 36 trials
Page 1 / 2

Organizations

Research & Development (39)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Agenus Inc.For profit25542021
National Cancer Institute (NCI)Government6022023
City of Hope National Medical CenterAcademic/Hospital4412023
Harvard UniversityAcademic/Hospital3222021
Memorial Sloan-Kettering Cancer CenterAcademic/Hospital3312024
Cornell UniversityAcademic/Hospital2212022
Johns Hopkins UniversityAcademic/Hospital2222024
Northwestern UniversityAcademic/Hospital2222021
Targovax ASAFor profit2112022
Australasian Gastro-Intestinal Trials GroupAcademic/Hospital1012025
Betta Pharmaceuticals Co.,Ltd.For profit1012021
British Columbia Cancer AgencyAcademic/Hospital1012025
Canadian Cancer Trials GroupAcademic/Hospital1112025
CarTheraFor profit1012024
Centre Leon BerardAcademic/Hospital1112024
Department of DefenseGovernment1012024
Duke UniversityAcademic/Hospital1112024
European Network for Gynaecological Oncological TrialAcademic/Hospital1012021
Gateway for Cancer ResearchAcademic/Hospital1012024
Georgetown UniversityAcademic/Hospital1012023
39 organizations
Page 1 / 2